---
document_datetime: 2025-12-02 06:36:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zurampic.html
document_name: zurampic.html
version: success
processing_time: 0.1053663
conversion_datetime: 2025-12-25 03:45:57.464288
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zurampic

[RSS](/en/individual-human-medicine.xml/66018)

##### Withdrawn

This medicine's authorisation has been withdrawn

lesinurad Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Zurampic](#news-on)
- [Related information](#related-information-587)
- [More information on Zurampic](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 July 2020, the European Commission issued a notification that the marketing authorisation for Zurampic (lesinurad) in the European Union (EU) had been withdrawn. The withdrawal was at the request of the marketing authorisation holder, Grunenthal GmbH, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Zurampic was granted marketing authorisation in the EU on 18 February 2016 for treatment of hyperuricaemia. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for Zurampic is updated to indicate that the marketing authorisation is no longer valid.

Zurampic : EPAR - Summary for the public

English (EN) (670.89 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/overview/zurampic-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-706)

български (BG) (766.38 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/bg/documents/overview/zurampic-epar-summary-public_bg.pdf)

español (ES) (667.19 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/es/documents/overview/zurampic-epar-summary-public_es.pdf)

čeština (CS) (745.71 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/cs/documents/overview/zurampic-epar-summary-public_cs.pdf)

dansk (DA) (665.65 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/da/documents/overview/zurampic-epar-summary-public_da.pdf)

Deutsch (DE) (675 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/de/documents/overview/zurampic-epar-summary-public_de.pdf)

eesti keel (ET) (664.65 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/et/documents/overview/zurampic-epar-summary-public_et.pdf)

ελληνικά (EL) (797.09 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/el/documents/overview/zurampic-epar-summary-public_el.pdf)

français (FR) (669.95 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fr/documents/overview/zurampic-epar-summary-public_fr.pdf)

hrvatski (HR) (692.16 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hr/documents/overview/zurampic-epar-summary-public_hr.pdf)

italiano (IT) (665.27 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/it/documents/overview/zurampic-epar-summary-public_it.pdf)

latviešu valoda (LV) (745.3 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lv/documents/overview/zurampic-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (696.61 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lt/documents/overview/zurampic-epar-summary-public_lt.pdf)

magyar (HU) (740.39 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hu/documents/overview/zurampic-epar-summary-public_hu.pdf)

Malti (MT) (748.22 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/mt/documents/overview/zurampic-epar-summary-public_mt.pdf)

Nederlands (NL) (666.54 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/nl/documents/overview/zurampic-epar-summary-public_nl.pdf)

polski (PL) (745.3 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pl/documents/overview/zurampic-epar-summary-public_pl.pdf)

português (PT) (667.58 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pt/documents/overview/zurampic-epar-summary-public_pt.pdf)

română (RO) (695.55 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/ro/documents/overview/zurampic-epar-summary-public_ro.pdf)

slovenčina (SK) (745.61 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sk/documents/overview/zurampic-epar-summary-public_sk.pdf)

slovenščina (SL) (736.92 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sl/documents/overview/zurampic-epar-summary-public_sl.pdf)

Suomi (FI) (665.54 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fi/documents/overview/zurampic-epar-summary-public_fi.pdf)

svenska (SV) (666.38 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sv/documents/overview/zurampic-epar-summary-public_sv.pdf)

Zurampic : EPAR - Risk-management-plan summary

English (EN) (646.13 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/rmp-summary/zurampic-epar-risk-management-plan-summary_en.pdf)

## Product information

Zurampic : EPAR - Product Information

English (EN) (954.17 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 06/07/2017

[View](/en/documents/product-information/zurampic-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-402)

български (BG) (1.76 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/bg/documents/product-information/zurampic-epar-product-information_bg.pdf)

español (ES) (1.11 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/es/documents/product-information/zurampic-epar-product-information_es.pdf)

čeština (CS) (1.44 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/cs/documents/product-information/zurampic-epar-product-information_cs.pdf)

dansk (DA) (1007.97 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/da/documents/product-information/zurampic-epar-product-information_da.pdf)

Deutsch (DE) (989.18 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/de/documents/product-information/zurampic-epar-product-information_de.pdf)

eesti keel (ET) (952.47 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/et/documents/product-information/zurampic-epar-product-information_et.pdf)

ελληνικά (EL) (1.72 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/el/documents/product-information/zurampic-epar-product-information_el.pdf)

français (FR) (1019.21 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/fr/documents/product-information/zurampic-epar-product-information_fr.pdf)

hrvatski (HR) (965.33 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/hr/documents/product-information/zurampic-epar-product-information_hr.pdf)

íslenska (IS) (998.87 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/is/documents/product-information/zurampic-epar-product-information_is.pdf)

italiano (IT) (998.56 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/it/documents/product-information/zurampic-epar-product-information_it.pdf)

latviešu valoda (LV) (1.65 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/lv/documents/product-information/zurampic-epar-product-information_lv.pdf)

lietuvių kalba (LT) (995.1 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/lt/documents/product-information/zurampic-epar-product-information_lt.pdf)

magyar (HU) (1.44 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/hu/documents/product-information/zurampic-epar-product-information_hu.pdf)

Malti (MT) (1.48 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/mt/documents/product-information/zurampic-epar-product-information_mt.pdf)

Nederlands (NL) (969.94 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/nl/documents/product-information/zurampic-epar-product-information_nl.pdf)

norsk (NO) (1.06 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/no/documents/product-information/zurampic-epar-product-information_no.pdf)

polski (PL) (1.44 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/pl/documents/product-information/zurampic-epar-product-information_pl.pdf)

português (PT) (994.6 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/pt/documents/product-information/zurampic-epar-product-information_pt.pdf)

română (RO) (1012.13 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/ro/documents/product-information/zurampic-epar-product-information_ro.pdf)

slovenčina (SK) (1.53 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sk/documents/product-information/zurampic-epar-product-information_sk.pdf)

slovenščina (SL) (1.51 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sl/documents/product-information/zurampic-epar-product-information_sl.pdf)

Suomi (FI) (973.31 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/fi/documents/product-information/zurampic-epar-product-information_fi.pdf)

svenska (SV) (962.77 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sv/documents/product-information/zurampic-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IA/0008 15/06/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Zurampic : EPAR - All Authorised presentations

English (EN) (602.77 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 06/07/2017

[View](/en/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-472)

български (BG) (625.33 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/bg/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_bg.pdf)

español (ES) (600.63 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/es/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_es.pdf)

čeština (CS) (617.96 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/cs/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (602.13 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/da/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (602.13 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/de/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (594.5 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/et/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (624.82 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/el/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_el.pdf)

français (FR) (600.35 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/fr/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (601.1 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/hr/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (601.08 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/is/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_is.pdf)

italiano (IT) (600.85 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/it/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (618.91 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/lv/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (601.91 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/lt/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (617.04 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/hu/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (618.15 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/mt/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (600.81 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/nl/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (602 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/no/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_no.pdf)

polski (PL) (617.96 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/pl/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_pl.pdf)

português (PT) (601.06 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/pt/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_pt.pdf)

română (RO) (600.99 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/ro/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (618.33 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sk/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (616.75 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sl/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (600.56 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/fi/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (600.56 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

06/07/2017

[View](/sv/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Zurampic Active substance lesinurad International non-proprietary name (INN) or common name lesinurad Therapeutic area (MeSH) Hyperuricemia Anatomical therapeutic chemical (ATC) code M04AB05

### Pharmacotherapeutic group

Antigout preparations

### Therapeutic indication

Zurampic, in combination with a xanthine oxidase inhibitor, is indicated in adults for the adjunctive treatment of hyperuricaemia in gout patients (with or without tophi) who have not achieved target serum uric acid levels with an adequate dose of a xanthine oxidase inhibitor alone.

## Authorisation details

EMA product number EMEA/H/C/003932 Marketing authorisation holder

Grünenthal GmbH

Zieglerstr. 6

Marketing authorisation issued 18/02/2016 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Zurampic : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (765.72 KB - PDF)

**First published:** 02/09/2016

**Last updated:** 27/07/2020

[View](/en/documents/procedural-steps-after/zurampic-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Zurampic : EPAR - Public assessment report

Adopted

Reference Number: EMA/6459/2016

English (EN) (5.54 MB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/assessment-report/zurampic-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Zurampic

Adopted

Reference Number: EMA/CHMP/824058/2015

English (EN) (677.31 KB - PDF)

**First published:** 18/12/2015

**Last updated:** 18/12/2015

[View](/en/documents/smop-initial/chmp-summary-opinion-zurampic_en.pdf)

#### News on Zurampic

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 December 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-december-2015) 18/12/2015

#### Related information

- [Zurampic: Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/search?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-1=1=EMEAHC0039320000) (initial marketing authorisation)

#### More information on Zurampic

- [An Observational Post-Authorisation Safety Study of Lesinurad Patients (SATURATES) - post-authorisation study](https://catalogues.ema.europa.eu/study/44348)

**This page was last updated on** 31/07/2020

## Share this page

[Back to top](#main-content)